Find a Doctor
Michael Vogelbaum, MD, PhD
Program Leader, Department of Neuro-OncologyChief of NeurosurgerySpecialty: Neurosurgery
Cancer Focus: Brain Cancer, Glioblastoma, Neurofibromatosis
Dr. Vogelbaum is an internationally known leader in neurosurgical oncology and distinguished investigator in laboratory research, translational and clinical trials in gliomas, a dangerous type of brain cancer. Dr. Vogelbaum is currently Chief of Neurosurgery and Program Leader of the Department of Neuro-Oncology at Moffitt Cancer Center. He has served on or led numerous scientific committees and holds an array of honors and awards, as well as leadership positions at the regional, national and international level. He is the principal investigator and co-investigator of a broad range of early phase investigator-initiated therapeutic trials, both national and international multisite collaborative studies. He has published over 190 peer-reviewed and invited articles. He has written nine book chapters and co-edited one book: “Principles and Practice of Neuro-Oncology – A Multidisciplinary Approach.” He was the recipient of the prestigious American Association of Neurological Surgeons Young Clinician Investigator Award. Dr. Vogelbaum also is the inventor of patented medical devices for delivering therapeutics directly to the brain and brain tumors. The first of these devices has received FDA clearance. After completing his MD and PhD (Biomedical Engineering) at the University of Virginia, Dr. Vogelbaum completed his residency in neurological surgery at Barnes-Jewish Hospital in St. Louis, MO. He spent almost two decades at the Cleveland Clinic Foundation, where he developed recognition as a world-renowned expert in the diagnosis and treatment of benign and malignant tumors of the brain and spinal cord. He is a clinical/translational research scientist with particular expertise and academic interest in stereotactic (image-guided) brain surgery, radiosurgery, the biology of brain tumors, and the development of novel anti-cancer treatments. He has received support and funding from the American Cancer Society, the National Institutes of Health and the Wolf Family Foundation.
Education & Training
If you believe you are eligible for one of these trials or studies, please call
Title: Deciphering MDSC Function for GBM Targeting
32 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.Learn more about our patient comments
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including: